Cargando…
Stereotactic body radiation therapy use for high risk prostate cancer in the United States
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116349/ https://www.ncbi.nlm.nih.gov/pubmed/33188271 http://dx.doi.org/10.1038/s41391-020-00300-5 |
_version_ | 1783691383586947072 |
---|---|
author | Patel, Sagar A. Switchenko, Jeffrey M. Kishan, Amar U. Jani, Ashesh B. Royce, Trevor J. Fischer-Valuck, Benjamin W. |
author_facet | Patel, Sagar A. Switchenko, Jeffrey M. Kishan, Amar U. Jani, Ashesh B. Royce, Trevor J. Fischer-Valuck, Benjamin W. |
author_sort | Patel, Sagar A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8116349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81163492021-06-01 Stereotactic body radiation therapy use for high risk prostate cancer in the United States Patel, Sagar A. Switchenko, Jeffrey M. Kishan, Amar U. Jani, Ashesh B. Royce, Trevor J. Fischer-Valuck, Benjamin W. Prostate Cancer Prostatic Dis Correspondence Nature Publishing Group UK 2020-11-13 2021 /pmc/articles/PMC8116349/ /pubmed/33188271 http://dx.doi.org/10.1038/s41391-020-00300-5 Text en © The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Patel, Sagar A. Switchenko, Jeffrey M. Kishan, Amar U. Jani, Ashesh B. Royce, Trevor J. Fischer-Valuck, Benjamin W. Stereotactic body radiation therapy use for high risk prostate cancer in the United States |
title | Stereotactic body radiation therapy use for high risk prostate cancer in the United States |
title_full | Stereotactic body radiation therapy use for high risk prostate cancer in the United States |
title_fullStr | Stereotactic body radiation therapy use for high risk prostate cancer in the United States |
title_full_unstemmed | Stereotactic body radiation therapy use for high risk prostate cancer in the United States |
title_short | Stereotactic body radiation therapy use for high risk prostate cancer in the United States |
title_sort | stereotactic body radiation therapy use for high risk prostate cancer in the united states |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116349/ https://www.ncbi.nlm.nih.gov/pubmed/33188271 http://dx.doi.org/10.1038/s41391-020-00300-5 |
work_keys_str_mv | AT patelsagara stereotacticbodyradiationtherapyuseforhighriskprostatecancerintheunitedstates AT switchenkojeffreym stereotacticbodyradiationtherapyuseforhighriskprostatecancerintheunitedstates AT kishanamaru stereotacticbodyradiationtherapyuseforhighriskprostatecancerintheunitedstates AT janiasheshb stereotacticbodyradiationtherapyuseforhighriskprostatecancerintheunitedstates AT roycetrevorj stereotacticbodyradiationtherapyuseforhighriskprostatecancerintheunitedstates AT fischervaluckbenjaminw stereotacticbodyradiationtherapyuseforhighriskprostatecancerintheunitedstates |